{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:26:21Z","timestamp":1773282381730,"version":"3.50.1"},"reference-count":19,"publisher":"SLACK, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmic Surg Lasers Imaging Retina"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>The response to combined laser photocoagulation and a single intravitreal injection of 0.75 mg bevacizumab to each eye on separate days in two patients with aggressive, posterior retinopathy of prematurity (ROP) is described. Combined treatment resulted in regression of zone-1 disease in Case 1, which had no retinal detachment. However, no significant regression or unfavorable anatomic response was observed in the second case with retinal detachment. Although the combination of laser photocoagulation and intravitreal bevacizumab injection seems to be well tolerated, inducing prompt regression of agressive zone-1 ROP without retinal detachment, further controlled studies with long-term follow-up are necessary for their use in the treatment of ROP with for potentially dangerous growth factor inhibitors in premature babies.<\/jats:p>","DOI":"10.3928\/15428877-20100215-03","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T19:04:29Z","timestamp":1269543869000},"page":"1-5","source":"Crossref","is-referenced-by-count":18,"title":["Combination of Laser Photocoagulation and Intravitreal Bevacizumab in Aggressive Posterior Retinopathy of Prematurity"],"prefix":"10.3928","volume":"41","author":[{"given":"Halil Ibrahim","family":"Altinsoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih Mehmet","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u0131za","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. \u00dcmit","family":"Sarici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.12.1684"},{"key":"e_1_3_1_3_2","first-page":"512","article-title":"VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP","volume":"10","author":"McColm JR","year":"2004","unstructured":"McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis. 2004;10:512\u2013520.","journal-title":"Mol Vis"},{"key":"e_1_3_1_4_2","first-page":"105","article-title":"Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity","volume":"1","author":"Young TL","year":"1997","unstructured":"Young TL, Anthony DC, Pierce E, Foley E, Smith LE. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. JAAPOS. 1997;1:105\u2013110.","journal-title":"JAAPOS"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(03)00119-2"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140410008"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2000.00226.x"},{"key":"e_1_3_1_8_2","first-page":"97","volume-title":"Angiogenesis Meeting","author":"Trese MT","unstructured":"Trese MT. Anti-angiogenesis therapy for early and late retinopathy of prematurity. Angiogenesis Meeting 23\u201324 February 2007; Bascom Palmer Florida, USA, 97."},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.02.018"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-007-0661-y"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.3928\/15428877-20070501-09"},{"key":"e_1_3_1_12_2","first-page":"532","article-title":"Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)","volume":"12","author":"Lutty GA","year":"2006","unstructured":"Lutty GA, Chan-Ling T, Phelps DL. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis. 2006;12:532\u2013580.","journal-title":"Mol Vis"},{"key":"e_1_3_1_13_2","first-page":"474","article-title":"Localization of VEGF receptor-2 (KDR\/Flk-1) and effects of blocking it in oxygen-induced retinopathy","volume":"43","author":"McLeod DS","year":"2002","unstructured":"McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA. Localization of VEGF receptor-2 (KDR\/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002;43: 474\u2013482.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_14_2","first-page":"99","volume-title":"Angiogenesis Meeting","author":"Quiroz-Mercado H","unstructured":"Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RVP. Antiangiogenic therapy with intravitreal bevacizumab for the treatment of retinopathy of prematurity. Angiogenesis Meeting, 23\u201324 February 2007, Bascom Palmer Florida, USA, 99\u2013119."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0786-7"},{"key":"e_1_3_1_16_2","article-title":"Efficacy of Intravitreal Injection of Bevacizumab for Severe Retinopathy of Prematurity: A Pilot Study","author":"Kusaka S","unstructured":"Kusaka S, Shima C, Shimojyo H, Sato T, Fujikado T. Efficacy of Intravitreal Injection of Bevacizumab for Severe Retinopathy of Prematurity: A Pilot Study. Br J Ophthalmol. published online Jul 11 2008; 10.1136\/bjo. 2008.140657, [Epub ahead of print].","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.12.1711"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.19.11500"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(88)80638-9"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(97)90000-2"}],"container-title":["Ophthalmic Surgery, Lasers and Imaging Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/15428877-20100215-03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:44:42Z","timestamp":1683096282000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/15428877-20100215-03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.3928\/15428877-20100215-03"],"URL":"https:\/\/doi.org\/10.3928\/15428877-20100215-03","relation":{},"ISSN":["2325-8160","2325-8179"],"issn-type":[{"value":"2325-8160","type":"print"},{"value":"2325-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}